Gil Bornstein
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways
- Inflammasome and immune disorders
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
Papers in
-
- Vasculitis and related conditions 7
-
- Eosinophilic Disorders and Syndromes 3
- Rheumatoid Arthritis Research and Therapies 3
- Co-authors
- Avram Hershko (4 shared papers)Michele Pagano (3 shared papers)Dvora Ganoth (2 shared papers)Danielle Sitry-Shevah (1 shared paper)Keiko Nakayama (1 shared paper)Joanna Bloom (1 shared paper)Mike Tyers (1 shared paper)Tun Kiat Ko (1 shared paper)
- Journals
- Clinical Rheumatology (3 papers)Cancer (1 paper)Medicine (1 paper)Cell Division (1 paper)Postgraduate Medical Journal (1 paper)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Gil Bornstein
33 papers receiving 1.5k citations
Gil Bornstein's Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 676
- Molecular Biology 1.1k
- Cell Biology 208
- Nephrology 88
- Hematology 123
Countries citing papers authored by Gil Bornstein
This map shows the geographic impact of Gil Bornstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Bornstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Bornstein more than expected).
Fields of papers citing papers by Gil Bornstein
This network shows the impact of papers produced by Gil Bornstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Bornstein. The network helps show where Gil Bornstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Gil Bornstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27 Hit paper breakdown → | 2001 | 414 |
| 2 | Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase Hit paper breakdown → | 2003 | 401 |
| 3 | 2001 | 157 | |
| 4 | 2016 | 132 | |
| 5 | 2006 | 113 | |
| 6 | 2013 | 32 | |
| 7 | 2015 | 28 | |
| 8 | 2016 | 26 | |
| 9 | 2019 | 18 | |
| 10 | 2014 | 18 | |
| 11 | 2016 | 17 | |
| 12 | 2022 | 17 | |
| 13 | 2018 | 17 | |
| 14 | 2022 | 15 | |
| 15 | 2016 | 14 | |
| 16 | 2019 | 14 | |
| 17 | Is temporal artery biopsy essential in all cases of suspected giant cell arteritis? | 2015 | 14 |
| 18 | 2023 | 13 | |
| 19 | 2018 | 11 | |
| 20 | 2016 | 11 |
About Gil Bornstein
Gil Bornstein is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Molecular Biology, Nephrology and Epidemiology, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include Vasculitis and related conditions (7 papers), Ubiquitin and proteasome pathways (5 papers), Cell Adhesion Molecules Research (3 papers), Kawasaki Disease and Coronary Complications (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Oncology (676 citations), Molecular Biology (1.1k citations), Cell Biology (208 citations), Nephrology (88 citations) and Hematology (123 citations). Gil Bornstein has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Avram Hershko, Michele Pagano, Dvora Ganoth, Danielle Sitry-Shevah, Keiko Nakayama, Joanna Bloom, Mike Tyers, Tun Kiat Ko, Brett Larsen and Chagai Grossman. Their work appears in journals such as Clinical Rheumatology, Cancer, Medicine, Cell Division and Postgraduate Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.